$crlbf Cresco labs 313% revenue growth in cannabis & no debt.
From what we can see the company is doing things right and they acquisitions seem to be a great strategy in getting a larger footprint in the states that hold the greatest value.
To best analyse the company, we have attached a small section of the transcript from the most recent earnings report.
EARNINGS TRANSCRIPT
"In the first quarter, we generated revenue of $21.1 million, a 313% year-over-year increase, compared to Q1 of 2018 and a 24% sequential increase quarter-over-quarter. Q1’s proforma revenue was equal to $33.9 million, and importantly, we delivered another quarter of positive adjusted EBITDA. We couldn’t be happier with what we’ve been able to accomplish so far this year.Cresco generated Q1 gross profit of $9.4 million or 44.6% of revenue, compared to gross profit at $2.2 million or 43.6% of revenues for the comparable prior year period.We expect our gross profit margins to continue to improve over time as we leverage the infrastructure associated with scaling the business and expanding our production capabilities in several markets.Turning to the balance sheet and liquidity measures, Cresco is low capitalized to execute on its strategic initiatives in the coming year. As of March 31, 2019, Cresco had total assets of over 364 million, including cash and cash equivalents of $106.1 million. The company has a working capital position of approximately $146 million with no debt on the balance sheet."
We would suggest you make the effort to read the entire transcript as it paints a very positive future for the company.
AVERAGE ANALYSTS PRICE TARGET$19.20
AVERAGE ANALYSTS RECOMMENDATION BUY
To best analyse the company, we have attached a small section of the transcript from the most recent earnings report.
EARNINGS TRANSCRIPT
"In the first quarter, we generated revenue of $21.1 million, a 313% year-over-year increase, compared to Q1 of 2018 and a 24% sequential increase quarter-over-quarter. Q1’s proforma revenue was equal to $33.9 million, and importantly, we delivered another quarter of positive adjusted EBITDA. We couldn’t be happier with what we’ve been able to accomplish so far this year.Cresco generated Q1 gross profit of $9.4 million or 44.6% of revenue, compared to gross profit at $2.2 million or 43.6% of revenues for the comparable prior year period.We expect our gross profit margins to continue to improve over time as we leverage the infrastructure associated with scaling the business and expanding our production capabilities in several markets.Turning to the balance sheet and liquidity measures, Cresco is low capitalized to execute on its strategic initiatives in the coming year. As of March 31, 2019, Cresco had total assets of over 364 million, including cash and cash equivalents of $106.1 million. The company has a working capital position of approximately $146 million with no debt on the balance sheet."
We would suggest you make the effort to read the entire transcript as it paints a very positive future for the company.
AVERAGE ANALYSTS PRICE TARGET$19.20
AVERAGE ANALYSTS RECOMMENDATION BUY